Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Allogene Therapeutics (ALLO) Interest Coverage Ratio: 2024-2025

Historic Interest Coverage Ratio for Allogene Therapeutics (ALLO) over the last 1 years, with Sep 2025 value amounting to -130.53.

  • Allogene Therapeutics' Interest Coverage Ratio rose 81.81% to -130.53 in Q3 2025 from the same period last year, while for Sep 2025 it was -269.75, marking a year-over-year change of. This contributed to the annual value of -1,509.39 for FY2024, which is N/A change from last year.
  • Allogene Therapeutics' Interest Coverage Ratio amounted to -130.53 in Q3 2025, which was up 38.43% from -212.01 recorded in Q2 2025.
  • In the past 5 years, Allogene Therapeutics' Interest Coverage Ratio ranged from a high of -130.53 in Q3 2025 and a low of -746.79 during Q4 2024.
  • In the last 2 years, Allogene Therapeutics' Interest Coverage Ratio had a median value of -434.61 in 2025 and averaged -448.33.
  • Data for Allogene Therapeutics' Interest Coverage Ratio shows a peak YoY soared of 81.81% (in 2025) over the last 5 years.
  • Allogene Therapeutics' Interest Coverage Ratio (Quarterly) stood at -746.79 in 2024, then spiked by 81.81% to -130.53 in 2025.
  • Its last three reported values are -130.53 in Q3 2025, -212.01 for Q2 2025, and -434.61 during Q1 2025.